Mar 2, 2021 by Jason HawthorneWhere Will Pfizer Be in 1 Year?The company will face competition on many fronts before 2022 arrives.
Feb 28, 2021 by Jason HawthorneHave $1,000? This Is the Best Coronavirus Stock to Buy NowMassive growth from COVID testing is hiding an excellent business.
Feb 27, 2021 by Jason Hawthorne3 Green Flags for Johnson & Johnson's FutureVaccine and product developments could boost growth for the healthcare icon.
Feb 27, 2021 by Jason HawthorneCoronavirus 2021: Where to Invest $1,000 Right NowThis healthcare staffing company is adding technology to its arsenal.
Feb 26, 2021 by Jason HawthorneWhere to Invest $10,000 in the Next Market CrashA proven strategy and new growth opportunities will help you sleep at night owning this winner.
Feb 25, 2021 by Jason HawthorneIf You Invested $1,000 in Intuitive Surgical's IPO, This Is How Much Money You'd Have NowAfter massive growth, the innovator in robotic surgery is getting predictable.
Feb 23, 2021 by Jason HawthorneCould Intuitive Surgical Be a Millionaire-Maker Stock?The answers to three questions point to continued gains ahead.
Feb 15, 2021 by Jason HawthorneBetter Coronavirus Stock: Inovio Pharmaceuticals vs. VaxartThe choice isn't easy, but simplicity may be the answer.
Feb 14, 2021 by Jason Hawthorne1 Green Flag and 1 Red Flag for Novavax's Vaccine CandidateThe stock's gains could continue despite a chink in its armor.
Feb 13, 2021 by Jason Hawthorne1 Green Flag and 1 Red Flag for Johnson & Johnson's Vaccine CandidateA huge market awaits if the company can make enough doses.
Feb 12, 2021 by Jason HawthorneWhat Is Vaxart Worth Now?The company can still produce returns without a COVID vaccine.
Feb 11, 2021 by Jason Hawthorne3 Reasons Pfizer's Failures Could Lead to a Big AcquisitionA huge pivot could reopen doors to growth that seemed closed.
Feb 9, 2021 by Jason HawthorneForget Gamestop! This Highly Shorted Stock Is a Strong Buy NowThe unusual biotech could be a bitter pill for short sellers to swallow.
Feb 6, 2021 by Jason HawthorneIs Amazon's Healthcare Strategy Clear?The company is disrupting a new industry with an old strategy.
Feb 6, 2021 by Jason Hawthorne1 Green Flag and 1 Red Flag From Pfizer's EarningsUpdates on the COVID-19 vaccine and plans for a more focused structure dominated the release.
Feb 6, 2021 by Jason Hawthorne2 Healthcare IPOs to Watch in 2021Convenience is key for these promising companies.
Feb 4, 2021 by Jason Hawthorne1 Major Problem for the Healthcare IndustryOne company's obstacle is another company's opportunity.
Feb 3, 2021 by Jason HawthorneIs It Too Late to Buy Pfizer Stock?Time to buy the drugmaker is running out.
Feb 2, 2021 by Jason Hawthorne3 Stocks I'll Be Buying When the Market Crashes AgainA market sell-off won't change the trends that are making these companies winners
Feb 2, 2021 by Jason HawthorneCould Teladoc Be a Millionaire-Maker Stock?Management's guidance suggests plenty of upside for the stock.
